Cargando…

Rifampin modulation of xeno‐ and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes

Rifampin is a pleiotropic inducer of multiple drug metabolizing enzymes and transporters. This work utilized a global approach to evaluate rifampin effects on conjugating enzyme gene expression with relevance to human xeno‐ and endo‐biotic metabolism. Primary human hepatocytes from 7 subjects were t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gufford, Brandon T., Robarge, Jason D., Eadon, Michael T., Gao, Hongyu, Lin, Hai, Liu, Yunlong, Desta, Zeruesenay, Skaar, Todd C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869567/
https://www.ncbi.nlm.nih.gov/pubmed/29610665
http://dx.doi.org/10.1002/prp2.386
_version_ 1783309307744354304
author Gufford, Brandon T.
Robarge, Jason D.
Eadon, Michael T.
Gao, Hongyu
Lin, Hai
Liu, Yunlong
Desta, Zeruesenay
Skaar, Todd C.
author_facet Gufford, Brandon T.
Robarge, Jason D.
Eadon, Michael T.
Gao, Hongyu
Lin, Hai
Liu, Yunlong
Desta, Zeruesenay
Skaar, Todd C.
author_sort Gufford, Brandon T.
collection PubMed
description Rifampin is a pleiotropic inducer of multiple drug metabolizing enzymes and transporters. This work utilized a global approach to evaluate rifampin effects on conjugating enzyme gene expression with relevance to human xeno‐ and endo‐biotic metabolism. Primary human hepatocytes from 7 subjects were treated with rifampin (10 μmol/L, 24 hours). Standard methods for RNA‐seq library construction, EZBead preparation, and NextGen sequencing were used to measure UDP‐glucuronosyl transferase UGT, sulfonyltransferase SULT, N acetyltransferase NAT, and glutathione‐S‐transferase GST mRNA expression compared to vehicle control (0.01% MeOH). Rifampin‐induced (>1.25‐fold) mRNA expression of 13 clinically important phase II drug metabolizing genes and repressed (>1.25‐fold) the expression of 3 genes (P < .05). Rifampin‐induced miRNA expression changes correlated with mRNA changes and miRNAs were identified that may modulate conjugating enzyme expression. NAT2 gene expression was most strongly repressed (1.3‐fold) by rifampin while UGT1A4 and UGT1A1 genes were most strongly induced (7.9‐ and 4.8‐fold, respectively). Physiologically based pharmacokinetic modeling (PBPK) was used to simulate the clinical consequences of rifampin induction of CYP3A4‐ and UGT1A4‐mediated midazolam metabolism. Simulations evaluating isolated UGT1A4 induction predicted increased midazolam N‐glucuronide exposure (~4‐fold) with minimal reductions in parent midazolam exposure (~10%). Simulations accounting for simultaneous induction of both CYP3A4 and UGT1A4 predicted a ~10‐fold decrease in parent midazolam exposure with only a ~2‐fold decrease in midazolam N‐glucuronide metabolite exposure. These data reveal differential effects of rifampin on the human conjugating enzyme transcriptome and potential associations with miRNAs that form the basis for future mechanistic studies to elucidate the interplay of conjugating enzyme regulatory elements.
format Online
Article
Text
id pubmed-5869567
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58695672018-04-02 Rifampin modulation of xeno‐ and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes Gufford, Brandon T. Robarge, Jason D. Eadon, Michael T. Gao, Hongyu Lin, Hai Liu, Yunlong Desta, Zeruesenay Skaar, Todd C. Pharmacol Res Perspect Original Articles Rifampin is a pleiotropic inducer of multiple drug metabolizing enzymes and transporters. This work utilized a global approach to evaluate rifampin effects on conjugating enzyme gene expression with relevance to human xeno‐ and endo‐biotic metabolism. Primary human hepatocytes from 7 subjects were treated with rifampin (10 μmol/L, 24 hours). Standard methods for RNA‐seq library construction, EZBead preparation, and NextGen sequencing were used to measure UDP‐glucuronosyl transferase UGT, sulfonyltransferase SULT, N acetyltransferase NAT, and glutathione‐S‐transferase GST mRNA expression compared to vehicle control (0.01% MeOH). Rifampin‐induced (>1.25‐fold) mRNA expression of 13 clinically important phase II drug metabolizing genes and repressed (>1.25‐fold) the expression of 3 genes (P < .05). Rifampin‐induced miRNA expression changes correlated with mRNA changes and miRNAs were identified that may modulate conjugating enzyme expression. NAT2 gene expression was most strongly repressed (1.3‐fold) by rifampin while UGT1A4 and UGT1A1 genes were most strongly induced (7.9‐ and 4.8‐fold, respectively). Physiologically based pharmacokinetic modeling (PBPK) was used to simulate the clinical consequences of rifampin induction of CYP3A4‐ and UGT1A4‐mediated midazolam metabolism. Simulations evaluating isolated UGT1A4 induction predicted increased midazolam N‐glucuronide exposure (~4‐fold) with minimal reductions in parent midazolam exposure (~10%). Simulations accounting for simultaneous induction of both CYP3A4 and UGT1A4 predicted a ~10‐fold decrease in parent midazolam exposure with only a ~2‐fold decrease in midazolam N‐glucuronide metabolite exposure. These data reveal differential effects of rifampin on the human conjugating enzyme transcriptome and potential associations with miRNAs that form the basis for future mechanistic studies to elucidate the interplay of conjugating enzyme regulatory elements. John Wiley and Sons Inc. 2018-03-26 /pmc/articles/PMC5869567/ /pubmed/29610665 http://dx.doi.org/10.1002/prp2.386 Text en © 2018 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Gufford, Brandon T.
Robarge, Jason D.
Eadon, Michael T.
Gao, Hongyu
Lin, Hai
Liu, Yunlong
Desta, Zeruesenay
Skaar, Todd C.
Rifampin modulation of xeno‐ and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes
title Rifampin modulation of xeno‐ and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes
title_full Rifampin modulation of xeno‐ and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes
title_fullStr Rifampin modulation of xeno‐ and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes
title_full_unstemmed Rifampin modulation of xeno‐ and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes
title_short Rifampin modulation of xeno‐ and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes
title_sort rifampin modulation of xeno‐ and endobiotic conjugating enzyme mrna expression and associated micrornas in human hepatocytes
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869567/
https://www.ncbi.nlm.nih.gov/pubmed/29610665
http://dx.doi.org/10.1002/prp2.386
work_keys_str_mv AT guffordbrandont rifampinmodulationofxenoandendobioticconjugatingenzymemrnaexpressionandassociatedmicrornasinhumanhepatocytes
AT robargejasond rifampinmodulationofxenoandendobioticconjugatingenzymemrnaexpressionandassociatedmicrornasinhumanhepatocytes
AT eadonmichaelt rifampinmodulationofxenoandendobioticconjugatingenzymemrnaexpressionandassociatedmicrornasinhumanhepatocytes
AT gaohongyu rifampinmodulationofxenoandendobioticconjugatingenzymemrnaexpressionandassociatedmicrornasinhumanhepatocytes
AT linhai rifampinmodulationofxenoandendobioticconjugatingenzymemrnaexpressionandassociatedmicrornasinhumanhepatocytes
AT liuyunlong rifampinmodulationofxenoandendobioticconjugatingenzymemrnaexpressionandassociatedmicrornasinhumanhepatocytes
AT destazeruesenay rifampinmodulationofxenoandendobioticconjugatingenzymemrnaexpressionandassociatedmicrornasinhumanhepatocytes
AT skaartoddc rifampinmodulationofxenoandendobioticconjugatingenzymemrnaexpressionandassociatedmicrornasinhumanhepatocytes